Molecule Financial Statements From 2010 to 2024

EVRRF Stock  USD 0  0.00  0.00%   
Molecule Holdings financial statements provide useful quarterly and yearly information to potential Molecule Holdings investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Molecule Holdings financial statements helps investors assess Molecule Holdings' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Molecule Holdings' valuation are summarized below:
Molecule Holdings does not presently have any fundamental ratios for analysis.
Check Molecule Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Molecule Holdings' main balance sheet or income statement drivers, such as , as well as many indicators such as . Molecule financial statements analysis is a perfect complement when working with Molecule Holdings Valuation or Volatility modules.
  
This module can also supplement various Molecule Holdings Technical models . Check out the analysis of Molecule Holdings Correlation against competitors.

Molecule Holdings Company Operating Margin Analysis

Molecule Holdings' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Molecule Holdings Operating Margin

    
  (2.15) %  
Most of Molecule Holdings' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Molecule Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, Molecule Holdings has an Operating Margin of -2.1462%. This is 93.88% lower than that of the Metals & Mining sector and significantly lower than that of the Materials industry. The operating margin for all United States stocks is 61.05% lower than that of the firm.

Molecule Holdings Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Molecule Holdings's current stock value. Our valuation model uses many indicators to compare Molecule Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Molecule Holdings competition to find correlations between indicators driving Molecule Holdings's intrinsic value. More Info.
Molecule Holdings is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Molecule Holdings' earnings, one of the primary drivers of an investment's value.

About Molecule Holdings Financial Statements

Molecule Holdings stakeholders use historical fundamental indicators, such as Molecule Holdings' revenue or net income, to determine how well the company is positioned to perform in the future. Although Molecule Holdings investors may analyze each financial statement separately, they are all interrelated. For example, changes in Molecule Holdings' assets and liabilities are reflected in the revenues and expenses on Molecule Holdings' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Molecule Holdings. Please read more on our technical analysis and fundamental analysis pages.
Molecule Holdings Inc. engages in production and co-packing of cannabis-infused beverages in Canada. It offers its beverage products under the PHRESH, embody, and CANAJO brands. Molecule Holdings is traded on OTC Exchange in the United States.

Currently Active Assets on Macroaxis

Other Information on Investing in Molecule Pink Sheet

Molecule Holdings financial ratios help investors to determine whether Molecule Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Molecule with respect to the benefits of owning Molecule Holdings security.